Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine D3 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Homo sapiens | sigma non-opioid intracellular receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | ko:K04145 dopamine receptor D2, putative | Dopamine D3 receptor | 446 aa | 426 aa | 28.6 % |
Echinococcus granulosus | alpha 1A adrenergic receptor | Dopamine D3 receptor | 446 aa | 460 aa | 21.1 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Dopamine D2 receptor | 444 aa | 440 aa | 30.0 % |
Schistosoma mansoni | amine GPCR | Dopamine D3 receptor | 446 aa | 420 aa | 31.4 % |
Onchocerca volvulus | Glycoprotein hormone beta 5 homolog | Dopamine D3 receptor | 446 aa | 489 aa | 22.9 % |
Loa Loa (eye worm) | hypothetical protein | Dopamine D3 receptor | 446 aa | 425 aa | 21.4 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Dopamine D2 receptor | 444 aa | 429 aa | 31.7 % |
Echinococcus multilocularis | serotonin receptor | Dopamine D2 receptor | 444 aa | 428 aa | 31.3 % |
Echinococcus multilocularis | alpha 1A adrenergic receptor | Dopamine D3 receptor | 446 aa | 473 aa | 21.6 % |
Schistosoma mansoni | biogenic amine (dopamine) receptor | Dopamine D2 receptor | 444 aa | 494 aa | 26.3 % |
Schistosoma japonicum | ko:K04207 neuropeptide Y receptor Y5, putative | Dopamine D2 receptor | 444 aa | 386 aa | 19.7 % |
Schistosoma mansoni | muscarinic acetylcholine (GAR) receptor | Dopamine D2 receptor | 444 aa | 487 aa | 23.8 % |
Schistosoma japonicum | Octopamine receptor, putative | Dopamine D3 receptor | 446 aa | 501 aa | 28.5 % |
Onchocerca volvulus | RB1-inducible coiled-coil protein 1 homolog | Dopamine D3 receptor | 446 aa | 478 aa | 22.8 % |
Loa Loa (eye worm) | TYRA-2 protein | Dopamine D3 receptor | 446 aa | 494 aa | 24.3 % |
Echinococcus multilocularis | biogenic amine (5HT) receptor | Dopamine D3 receptor | 446 aa | 499 aa | 30.9 % |
Echinococcus multilocularis | g protein coupled receptor | Dopamine D2 receptor | 444 aa | 465 aa | 21.5 % |
Schistosoma mansoni | ancient conserved domain protein 2 (cyclin m2) | Dopamine D3 receptor | 446 aa | 463 aa | 25.5 % |
Onchocerca volvulus | Dopamine D3 receptor | 446 aa | 462 aa | 26.0 % | |
Echinococcus granulosus | g protein coupled receptor | Dopamine D2 receptor | 444 aa | 457 aa | 21.0 % |
Schistosoma japonicum | ko:K04145 dopamine receptor D2, putative | Dopamine D3 receptor | 446 aa | 463 aa | 29.8 % |
Schistosoma mansoni | biogenic amine receptor | Dopamine D3 receptor | 446 aa | 455 aa | 28.6 % |
Onchocerca volvulus | Dopamine D3 receptor | 446 aa | 434 aa | 19.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | transient receptor potential cation channel subfamily A member | 0.0191 | 0.2716 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0163 | 0.1909 | 0.1909 |
Echinococcus granulosus | carboxylesterase 5A | 0.0163 | 0.1909 | 0.6494 |
Echinococcus granulosus | ankyrin repeat protein | 0.0191 | 0.2716 | 0.924 |
Echinococcus multilocularis | ankyrin repeat protein | 0.0191 | 0.2716 | 0.924 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0445 | 1 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0163 | 0.1909 | 0.7028 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0163 | 0.1909 | 0.6494 |
Brugia malayi | Carboxylesterase family protein | 0.0163 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.3757 | 0.3757 |
Echinococcus multilocularis | acetylcholinesterase | 0.0163 | 0.1909 | 0.6494 |
Echinococcus multilocularis | acetylcholinesterase | 0.0163 | 0.1909 | 0.6494 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0199 | 0.294 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.1909 | 0.1909 |
Echinococcus granulosus | acetylcholinesterase | 0.0163 | 0.1909 | 0.6494 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0445 | 1 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0163 | 0.1909 | 0.1909 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0445 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0199 | 0.294 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0163 | 0.1909 | 0.1909 |
Echinococcus granulosus | acetylcholinesterase | 0.0163 | 0.1909 | 0.6494 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.2 nM | Binding affinity for dopamine receptor D3 expressed in Sf9 cells using [125I]-IABN the radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 0.2 nM | Binding affinity for dopamine receptor D3 expressed in Sf9 cells using [125I]-IABN the radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 1.8 nM | Binding affinity for dopamine receptor D2 long expressed in Sf9 cells using [125I]-IABN radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 1.8 nM | Binding affinity for dopamine receptor D2 long expressed in Sf9 cells using [125I]-IABN radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 4.8 nM | Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H]-(+)-pentazocine as radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 4.8 nM | Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H]-(+)-pentazocine as radioligand. | ChEMBL. | 11356115 |
Ki (binding) | = 17 nM | Binding affinity for sigma-2 receptor measured on rat liver membranes using [3H]-DTG as radioligand in the presence of (+)-pentazocine | ChEMBL. | 11356115 |
Ratio (binding) | = 9 | Dopamine D2/D3 ratio of the compound | ChEMBL. | 11356115 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.